Skip to main content

Published locations for FDA approves dupilumab for treatment of prurigo nodularis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves dupilumab for treatment of prurigo nodularis

User login

  • Reset your password
  • /content/fda-approves-dupilumab-treatment-prurigo-nodularis
  • /edermatologynews/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo
  • /familypracticenews/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo
  • /internalmedicinenews/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo
  • /internalmedicine/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo
  • /dermatology/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo-nodularis
  • /familymedicine/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo-nodularis
  • /emergencymedicine/article/258300/medical-dermatology/fda-approves-dupilumab-treatment-prurigo